Dibromoacetic AcidInduces Hypothyroidism: From NetworkToxicology to SOCS1-Mediated Mechanistic Validation

Full abstract

Read the full abstract

Abstract Thyroid dysfunction affects hundreds of millions of people worldwide, yet the environmental contributors remain poorly characterized. Dibromoacetic acid (DBA), an unregulated brominated disinfection byproduct, is frequently detected in drinking water and is widely present in human populations. Despite its widespread human exposure, its potential to disrupt thyroid function and induce hypothyroidism has remained largely unexplored. To address this knowledge gap, we adopted an integrative strategy combining network toxicology, transcriptomics, and in vivo and in vitro experimental validation. Phenotypic results showed that in DBA-exposed SD rats, plasma thyroid hormone (TH) levels decreased, and thyroid histomorphology and ultrastructure were impaired. Mechanistically, DBA dysregulated thyroid miRNA expression, particularly upregulating miR-365–5p/miR-448–5p to downregulate SOCS1. Subsequently, SOCS1 depletion coupled with oxidative stress hyperactivated the Jak1/Stat1 signaling cascade, which, in turn, positively regulated YY1 to transcriptionally repress TPO in thyrocytes, ultimately suppressing TH synthesis. Moreover, DBA disrupted TH metabolism, transport, selenium trafficking, and receptor expression, further exacerbating the hypothyroidism. Taken together, our results identify DBA as an unrecognized thyroid-disrupting chemical beyond a simple unregulated drinking-water DBP. This integrative paradigm bridges computational prediction and mechanistic validation, establishing a reliable workflow to assess endocrine disruption triggered by poorly characterized DBPs and emerging environmental contaminants.